Cholic acid supplementation enhances cholesterol absorption in humans

Slides:



Advertisements
Similar presentations
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Advertisements

Liquid fructose supplementation in LDL-R−/− mice fed a western-type diet enhances lipid burden and atherosclerosis despite identical calorie consumption 
Volume 133, Issue 3, Pages (September 2007)
Volume 130, Issue 1, Pages (January 2006)
Volume 114, Issue 5, Pages (May 1998)
Volume 2, Issue 4, Pages (October 2005)
Bile Acid Synthesis in Humans Has a Rapid Diurnal Variation That Is Asynchronous With Cholesterol Synthesis  Cecilia Gälman, Bo Angelin, Mats Rudling 
Volume 146, Issue 4, Pages (April 2014)
Julian R. F. Walters, Ali M. Tasleem, Omer S. Omer, W
Michael Charlton, Bo Ahlman, K.Sreekumaran Nair  Gastroenterology 
Volume 137, Issue 4, Pages e3 (October 2009)
Volume 136, Issue 3, Pages (March 2009)
Volume 134, Issue 7, Pages (June 2008)
Volume 146, Issue 4, Pages (April 2014)
Volume 15, Issue 1, Pages (January 2012)
Volume 133, Issue 1, Pages (July 2007)
Volume 129, Issue 2, Pages (August 2005)
Volume 146, Issue 3, Pages (March 2014)
Outcomes Among Living Liver Donors
Human Diallelic Insertion/Deletion Polymorphisms
Volume 131, Issue 4, Pages (October 2006)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 118, Issue 3, Pages (March 2000)
The Role of Transsphincteric Pressure and Proximal Gastric Volume in Acid Reflux Before and After Fundoplication  Robert C.H. Scheffer, Hein G. Gooszen,
Volume 136, Issue 2, Pages e1 (February 2009)
Amani Al-Khaifi, Mats Rudling, Bo Angelin  Gastroenterology 
Volume 141, Issue 5, Pages (November 2011)
Incontinence severity and QOL scales for fecal incontinence
Effect of Peptide YY3–36 on Food Intake in Humans
Volume 120, Issue 5, Pages (April 2001)
Volume 154, Issue 5, Pages (April 2018)
Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy  Christina Reimer, Bo Søndergaard, Linda.
Targeting the FXR Nuclear Receptor to Treat Liver Disease
Volume 128, Issue 5, Pages (May 2005)
Constipation and the Microbiome: Lumen Versus Mucosa!
Volume 141, Issue 3, Pages e4 (September 2011)
Volume 130, Issue 6, Pages (May 2006)
Evidence That Gallbladder Epithelial Mucin Enhances Cholesterol Cholelithogenesis in MUC1 Transgenic Mice  Helen H. Wang, Nezam H. Afdhal, Sandra J. Gendler,
Volume 138, Issue 5, Pages (May 2010)
Volume 21, Issue 16, Pages (August 2011)
Volume 133, Issue 4, Pages (October 2007)
Rosa N. Chavez–Jauregui, Richard D. Mattes, Elizabeth J. Parks 
Laura Rotundo, Sushil Ahlawat  Gastroenterology 
Volume 132, Issue 3, Pages (March 2007)
Volume 93, Issue 5, Pages (May 1998)
Volume 130, Issue 1, Pages (January 2006)
Volume 137, Issue 1, Pages e5 (July 2009)
Volume 152, Issue 4, Pages (March 2017)
Colin Crooks, Tim Card, Joe West  Gastroenterology 
Michael Charlton, Bo Ahlman, K.Sreekumaran Nair  Gastroenterology 
Volume 145, Issue 6, Pages e5 (December 2013)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
When Bile Acids Don't Get Amidated
Volume 12, Issue 1, Pages (July 2010)
Swaroop Pendyala, Jeanne M. Walker, Peter R. Holt  Gastroenterology 
Covering the Cover Gastroenterology
Volume 126, Issue 3, Pages (March 2004)
Volume 128, Issue 5, Pages (May 2005)
Volume 130, Issue 1, Pages (January 2006)
Michelle Maria Pietzak  Gastroenterology 
Current Practice in the Diagnosis of Bile Acid Diarrhea
FIGURE 2 Stable isotope infusion protocol
Volume 140, Issue 3, Pages (March 2011)
Volume 133, Issue 3, Pages (September 2007)
Volume 152, Issue 4, Pages (March 2017)
The Future of Endoscopic Retrograde Cholangiopancreatography
Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment  Derek Gillen, Angela A. Wirz, Kenneth E.L.
Volume 21, Issue 16, Pages (August 2011)
Presentation transcript:

Cholic acid supplementation enhances cholesterol absorption in humans Laura A. Woollett, Donna D. Buckley, Lihang Yao, Peter J.H. Jones, Norman A. Granholm, Elizabeth A. Tolley, Patrick Tso, James E. Heubi  Gastroenterology  Volume 126, Issue 3, Pages 724-731 (March 2004) DOI: 10.1053/j.gastro.2003.11.058

Figure 1 Bile acid concentration in the lumen of subjects fed AHA heart-healthy diets while receiving CA or no bile acid supplement. On Day 14, subjects were given a standardized liquid meal and lumenal samples collected. Bile acid concentrations are shown for subjects consuming no bile acid supplements (A) or CA (B). Data are presented as unadjusted means ± SEM. Gastroenterology 2004 126, 724-731DOI: (10.1053/j.gastro.2003.11.058)

Figure 2 The distribution of cholesterol in micelles of lunemal samples of subjects after ingesting a standardized liquid meal while receiving CA or no bile acid supplements. Subjects consumed AHA heart-healthy diets plus or minus bile acid supplements for 14 days, after which time they consumed a standardized liquid meal and lumenal samples were collected. Lumenal samples were separated into micelles and nonmicellar particles at 3 different time points during collection. Data are presented as micrograms cholesterol per sample for subjects on diet alone (black) or CA plus diet (gray). Asterisk represents values significantly different from control values at same time point (P < 0.05). Data are presented as least square means ± SEM. Gastroenterology 2004 126, 724-731DOI: (10.1053/j.gastro.2003.11.058)

Figure 3 Cholesterol absorption is shown for each subject fed AHA heart-healthy diets while receiving CA or no bile acid supplement. On day 16, cholesterol absorption was determined with stable isotope. Samples were collected and analyzed as described in the Patients and Methods section. Data are presented as percentage cholesterol absorbed for each subject receiving CA or no supplement. Gastroenterology 2004 126, 724-731DOI: (10.1053/j.gastro.2003.11.058)

Figure 4 The fractional synthetic rates for each subject fed AHA heart-healthy diets while receiving CA or no bile acid supplements. On day 19, fractional synthetic rates were determined with stable isotope. Samples were collected and analyzed as described in the Patients and Methods section. Data are presented as pools of cholesterol synthesized each day for each subject receiving CA or no supplements. Gastroenterology 2004 126, 724-731DOI: (10.1053/j.gastro.2003.11.058)